11/13/2024
3:06 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:07 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:08 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 424B3 | |
10/07/2024
4:01 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
8:04 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
| Form 4/A | |
09/04/2024
8:52 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:53 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/04/2024
8:58 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:58 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:58 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:59 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:49 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:51 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:15 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form EFFECT | |
08/12/2024
3:20 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 424B3 | |
08/12/2024
3:15 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-K/A | |
08/05/2024
11:15 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form EFFECT | |
07/29/2024
3:11 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Grodnensky Oleg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:43 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
07/09/2024
7:06 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
7:02 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2024
3:27 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:09 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:07 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
8:05 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-K/A | |
05/14/2024
8:14 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
05/14/2024
8:15 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form ARS/A | |
05/03/2024
6:01 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:18 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
04/18/2024
5:22 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Park Seongsoo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
8:09 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4/A | |
04/12/2024
6:00 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:07 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
04/01/2024
4:27 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024
3:16 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
2:48 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q/A | |
03/29/2024
2:49 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
2:46 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:06 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
5:39 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:43 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
2024 Election Year Stocks: Uncover Hidden Gems! (Ad) In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link. |
03/21/2024
6:45 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:46 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:48 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:49 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:51 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:52 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
12:46 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
| Form SC 13G | |
11/22/2023
8:48 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
